%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/14656566.2018.1494154
en
Current and emerging treatment options for endometriosis
Simone Ferrero
Giulio Evangelisti
Fabio Barra
Taylor & Francis
Expert Opinion on Pharmacotherapy, 2018. doi:10.1080/14656566.2018.1494154
Endometriosis
combined oral contraceptives
progestins
gonadotropin-releasing hormone agonist
aromatase inhibitors
gonadotropin-releasing hormone antagonist
anti-angiogenetic
anti-oxidant
immunomodulators
Journal
Expert Opinion on Pharmacotherapy
© 2018 Informa UK Limited, trading as Taylor & Francis Group
1465-6566
1744-7666
00
00
1
17
10.1080/14656566.2018.1494154
https://doi.org/10.1080/14656566.2018.1494154
VoR
2018-07-04T14:24:40+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2018-07-06T01:50:13-07:00
2018-07-06T01:50:13-07:00
Endometriosis; combined oral contraceptives; progestins; gonadotropin-releasing hormone agonist; aromatase inhibitors; gonadotropin-releasing hormone antagonist; anti-angiogenetic; anti-oxidant; immunomodulators
iText 4.2.0 by 1T3XT
uuid:34b22ae8-4a9b-4e4e-8f32-0728ff77dda0
uuid:9617ed11-5756-4133-ab55-0f78e24aa7c2
2018-07-05truewww.tandfonline.com10.1080/14656566.2018.1494154www.tandfonline.comtrue2018-07-0510.1080/14656566.2018.1494154
endstream
endobj
4 0 obj
<>stream
xˮ\5l?_ 4XT]E/l}l>ye㷝+jE,h)1zy|Z7<P[K5ly~1ov_jOk&7pÕW *zuZ wNӞ{.?5MbZˮ$P+ko'DGbr~r&Ob`d|Va BK5R]:[\~\R'b%LF?_^OFnlcÙЗZDc4֊y1u=짰1Ui7Ą[ɵj|[毋;gy[KnC>ڄ-8e_}BE Y7U$$K.pF
6!x:X-brjzwݘL;|~ǃ|xj\F`71YD7h%$1^D]@YU,Df&\uC!}.>Dv.Wa x]t( Ǎ`D>(tSohd]_̻'hV/0WO+3膫]yźDC4Tgh܃?5W l$Gnq2=Y5f;5<5HZŇa<`$ݮ5j